Abstract
Purpose
The clinical significance of nodal micrometastasis is debated. Our primary objective was to determine whether, among women with early-stage breast cancer, regional lymph node micrometastasis is an independent risk factor for mortality. The secondary objective was to identify subgroups of women who have the highest risk of death from early-stage breast cancer with micrometastases.
Methods
206,625 women diagnosed with early-stage breast cancer (IA, IB, and IIA) from 2004 to 2012 were identified in the Surveillance, epidemiology, and end results database. Nodal status was classified as node-negative, isolated-tumor cells, micrometastases, and macrometastases. Women were classified into eight ethnic groups. Logistic regression was performed to estimate the odds ratio of being diagnosed with micrometastases. The Cox proportional hazard model was used to estimate the hazard ratio (HR) of breast cancer-specific death associated with micrometastases for each ethnic group.
Results
The 8-year breast cancer-specific survival was 96.6 % for women with node-negative breast cancers and was 94.6 % for women with micrometastases (adjusted HR 1.49; 95 % CI 1.31–1.69; P < .001). Among women with micrometastases, the 8-year breast cancer-specific survival was 95.1 % for white women and was 90.6 % for black women (HR 1.80; 95 % CI 1.29–2.52; P = .0006).
Conclusion(s)
Nodal micrometastasis is an independent risk factor for breast cancer mortality among women with early-stage breast cancer. Black women are more likely to die from breast cancer with micrometastases than white women.
Similar content being viewed by others
References
Rosen PR, Groshen S, Saigo PE et al (1989) A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol 7:355–366
Fisher B, Redmond C, Dimitrov NV et al (1989) A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. N Engl J Med 320:473–478
Mansour EG, Gray R, Shatila AH et al (1989) Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study. N Engl J Med 320:485–490
EBCTCG, Breast E, Trialists C et al (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687–1717
Bonadonna G, Valagussa P, Moliterni A et al (1995) Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up. N Engl J Med 332:901–906
Fisher ER, Anderson S, Redmond C et al (1993) Pathologic findings from the national surgical adjuvant breast project protocol B-06. 10-year pathologic and clinical prognostic discriminants. Cancer 71:2507–2514
Veronesi U (1993) Prognostic significance of number and level of axillary node metastases in breast cancer. Breast 2:224–228
Fitzgibbons PL, Page DL, Weaver D et al (2000) Prognostic factors in breast cancer. College of american pathologists consensus statement 1999. Arch Pathol Lab Med 124:966–978
Surveillance, epidemiology, and end results (SEER) program (www.seer.cancer.gov) SEER*stat database: incidence—SEER 18 regs research data + hurricane katrina impacted Louisiana cases, Nov 2014 sub (1973–2012 varying)—Linked To County Attributes—Tota
Reporting American Joint Committee on Cancer and End-Results (1977) Manual for staging of cancer, 1st edn. J.B. Lippincott, Philadelphia
Greene FL, Page DL, Fleming ID et al (2002) E: AJCC cancer staging manual, 6th edn. Springer, New York
Mittendorf EA, Ballman KV, McCall LM et al (2015) Evaluation of the stage IB designation of the American joint committee on cancer staging system in breast cancer. J Clin Oncol 33:1119–1127
Giuliano AE, Hawes D, Ballman KV et al (2011) Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. JAMA 306:385–393
Tan LK, Giri D, Hummer AJ et al (2008) Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up. J Clin Oncol 26:1803–1809
de Boer M, van Deurzen CHM, van Dijck JAAM et al (2009) Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med 361:653–663
Joslyn SA, Konety BR (2005) Effect of axillary lymphadenectomy on breast carcinoma survival. Breast Cancer Res Treat 91:11–18
Nurgalieva ZZ, Franzini L, Morgan RO et al (2013) Utilization of lymph node dissection, race/ethnicity, and breast cancer outcomes. Am J Manag Care 19:805–810
Chen SL, Hoehne FM, Giuliano AE (2007) The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Ann Surg Oncol 14:3378–3384
Maibenco DC, Dombi GW, Kau TY et al (2006) Significance of micrometastases on the survival of women with T1 breast cancer. Cancer 107:1234–1239
Kimbrough CW, McMasters KM, Quillo A et al (2015) Occult metastases in node-negative breast cancer: a surveillance, epidemiology, and end results-based analysis. Surgery 158:494–500
Weaver DL, Ashikaga T, Krag DN et al (2011) Effect of occult metastases on survival in node-negative breast cancer. N Engl J Med 364:412–421
Querzoli P, Pedriali M, Rinaldi R et al (2006) Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patients. Clin Cancer Res 12:6696–6701
Cunningham JE, Montero AJ, Garrett-Mayer E et al (2010) Racial differences in the incidence of breast cancer subtypes defined by combined histologic grade and hormone receptor status. Cancer Causes Control 21:399–409
Maskarinec G, Sen C, Koga K et al (2011) Ethnic differences in breast cancer survival: status and determinants. Womens Health 7:677–687
Aziz H, Hussain F, Sohn C et al (1999) Early onset of breast carcinoma in African American women with poor prognostic factors. Am J Clin Oncol 22:436–440
Silber JH, Rosenbaum PR, Clark AS et al (2013) Characteristics associated with differences in survival among black and white women with breast cancer. JAMA 310:389–397
Iqbal J, Ginsburg O, Rochon PA et al (2015) Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA 313:165–173
Surveillance research program, National cancer institute SEER*Stat software (www.seer.cancer.gov/seerstat) version 8.2.1
Schnitt SJ (2010) Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy. Mod Pathol 23(Suppl 2):S60–S64
Cote RJ, Peterson HF, Chaiwun B, International Breast Cancer Study Group et al (1999) Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. Lancet 354:896–900
Wasif N, Ye X, Giuliano AE (2009) Survey of ASCO members on management of sentinel node micrometastases in breast cancer: variation in treatment recommendations according to specialty. Ann Surg Oncol 16:2442–2449
National comprehensive cancer network. Breast cancer (version 1.2016). [Internet] 2 http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site. Accessed 16 Feb 2016
Acknowledgements
We acknowledge the National Comprehensive Cancer Network (NCCN) for the citation of the Clinical Practice Guidelines in Oncology, Breast Cancer Version 1.2016 (www.nccn.org).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors report no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The research ethics board of the Women’s College Research Institute/Women’s College Hospital, Toronto, Ontario approved this study.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Iqbal, J., Ginsburg, O., Giannakeas, V. et al. The impact of nodal micrometastasis on mortality among women with early-stage breast cancer. Breast Cancer Res Treat 161, 103–115 (2017). https://doi.org/10.1007/s10549-016-4015-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-016-4015-5